Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7375 p596
12 November 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


5mg Crestor dose for Asians

Asian patients and patients with predisposing factors for myopathy should start rosuvastatin (Crestor) treatment on a 5mg dose, AstraZeneca announced last week. AstraZeneca has launched 5mg tablets to enable this dose to be taken (see Notice-board p603).

Back to Top


©The Pharmaceutical Journal